Merck touts new Keytruda as patent cliff nears (NYSE:MRK)
Sundry Photography Merck (NYSE:MRK) is ramping up its R&D efforts to introduce a new version of the blockbuster cancer drug ...
Sundry Photography Merck (NYSE:MRK) is ramping up its R&D efforts to introduce a new version of the blockbuster cancer drug ...
Cliff Asness.Chris Goodney | Bloomberg | Getty ImagesCliff Asness' longest running multistrategy fund at AQR Capital Management returned 18.5% last year, ...
Mario Tama/Getty Images News Wells Fargo has lowered its rating on Johnson & Johnson (NYSE:JNJ) to equal weight, citing the ...
Aaron Freeman / Money Talks NewsIn this podcast, we’re talking about how parents help finance their kids’ education. Specifically, we’re ...
In this article Pending home sales dropped off significantly in August, pushing the real estate market to a standstill. With ...
The moratorium on federal student loan payments has been a financial boon to many households. But if and when the ...
On this week's episode of the Financial Planning Podcast, Cliff Corso explains why advisor demand for alternative investments creates distribution ...
Wall Street’s fear gauge has fallen to its lowest level in months, and Wall Street strategists are concerned it could ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.